Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Provincial Landscape
Snapshot: 2026-09-04
Qinghai Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 1 active clinical trials for multiple myeloma hosted across 1 tertiary medical centers in Qinghai (including Affiliated Hospital of Qinghai University).
Active Trials
1
Hospitals
1
Therapies
Bispecific & Multispecific Antibodies
Participating Medical Centers (1)
Affiliated Hospital of Qinghai University
Active Studies in Qinghai (1)
Population synthesized by CMDNShowing 0 published English records of 1 registry trials.
All 1 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.